Johnson Chemical Pharmaceutical Works Co., Ltd.

Taipei Exchange 4747.TWO

Johnson Chemical Pharmaceutical Works Co., Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: 37.53

Johnson Chemical Pharmaceutical Works Co., Ltd. Price to Earnings Ratio (P/E) is 37.53 on January 14, 2025, a 4.06% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. 52-week high Price to Earnings Ratio (P/E) is 41.59 on November 01, 2024, which is 10.83% above the current Price to Earnings Ratio (P/E).
  • Johnson Chemical Pharmaceutical Works Co., Ltd. 52-week low Price to Earnings Ratio (P/E) is 34.78 on August 05, 2024, which is -7.31% below the current Price to Earnings Ratio (P/E).
  • Johnson Chemical Pharmaceutical Works Co., Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is 37.83.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Taipei Exchange: 4747.TWO

Johnson Chemical Pharmaceutical Works Co., Ltd.

CEO Mr. Pai-Hsiung Huang
IPO Date June 28, 2012
Location
Headquarters No. 77 and No.79, Sanhe Road
Employees 167
Sector Health Care
Industries
Pharmaceuticals
Description

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorporated in 1959 and is based in New Taipei City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email